Investigating health issues caused by particulate matter from the World Trade Center disaster.
World Trade Center Particulate Matter Induced Cardiorespiratory and Vascular Dysfunction: a MultiOmic Approach
This study is looking at how breathing in dust from the World Trade Center collapse might affect your heart and lungs, especially for those who have conditions like asthma or heart disease, to help find better ways to diagnose and treat these health problems.
Quick facts
| Grant type | U01 cooperative agreement |
|---|---|
| Study type | NIH-funded research |
| Funding institution | New York University School of Medicine NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project ID | NIH-10842218 on NIH RePORTER |
What this research studies
This research focuses on understanding how exposure to particulate matter from the World Trade Center (WTC) destruction affects heart and lung health. It aims to explore the development of cardiorespiratory and vascular dysfunction in individuals exposed to WTC particulate matter, particularly looking at conditions like obstructive airway disease and cardiovascular disease. The study will utilize advanced multi-omic approaches to identify biological markers and mechanisms involved in these health issues, which could lead to better diagnosis and treatment options for affected individuals.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals who were exposed to particulate matter from the World Trade Center disaster, particularly those experiencing respiratory or cardiovascular symptoms.
Not a fit: Patients who have not been exposed to WTC particulate matter or do not exhibit related health issues may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved understanding and management of heart and lung diseases related to WTC particulate matter exposure.
How similar studies have performed: Previous research has shown that exposure to particulate matter can lead to significant health issues, indicating that this approach may yield valuable insights.
Where this research is happening
New York, United States
- New York University School of Medicine — New York, United States (Active)
Researchers
- Principal investigator: Nolan, Anna — New York University School of Medicine
- Study coordinator: Nolan, Anna
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.